I assume you work for AGN Irvine campus? By your language, it shows your intelligence and lack of courage. AGN hiring these type of people these days? I worked at AGN for close to 28 years (35 years in the industry) with 9 successful NDAs at AGN including appearing before FDA advisory board panels. What is your experience in the drug industry? BTW, the drug or its derivative has been in the clinic.
Will answer my own question. Saw CNBC interview and the CEO said they are expecting late first qtr or early 2nd qtr. Getting close.
I would tell you that you're full of $hit since its never been in the clinic yet! The other thing I would tell you is that I work on it now. So stop with your stupid #$%$ you joke!
Don't think so. What would you think if I told you I worked on the clinical research end of this for 4 years before I retired?
Problem is that lot of good employees have left or have been let go. These employees made AGN for what it was. No longer the same company as pre-2014.
Money talks and BS walks and the truth will soon dictate higher valuations . . .
These are real revenues and gross margins are over 90%
When have you EVER seen growth like this?
Millennium Healthcare (MHCC) sales:
2011 - $224,000 Reported
2012 - $1,686,000 Reported
2013 - $1,987,000 Reported
2014 - $17,000,000 - $7.4 million already reported and $10 million within days of reporting final year
2015 Estimated from pro forma - $50,000,000 plus
2016 Estimated from pro-forma - $100,000,000 plus
Shares are EXTREMELY cheap at $.15 (Fifteen cents) but not for long.
December quarter is close to being announced and earlier indications from company conference call indicated they could be 8 digits which will close 2014 out at $17,000,000 plus.
MHCC IS EXCEPTIONALLY STRONG BUY
Sentiment: Strong Buy
Got to admire your staying power. Nah, this pig is done. The deal is being done and its a good move for both companies. There is lots there for both. Two great platforms to merge.
You likely correct. This seems like a special situation conference with ACT and the dividend. May be taking some analysts' question while on a halt. At least that seems rational. Looks good; but, the ACT makes this a complex report. Quality of earnings is important. Good question.